Efficacy and safety evaluations of adalimumab biosimilars in the treatment of psoriasis
Purpose We aimed to systematically evaluate the efficacy and safety of adalimumab biosimilar agents in the treatment of moderate-to-severe plaque psoriasis, in order to provide evidence-based reference data for clinical medicine. Materials and Methods Five databases were searched by electronic retri...
Saved in:
Main Authors: | Changkun Li (Author), Yixuan Sunhe (Author), Hui Zhou (Author), Weihua Dong (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An Update Review of Biosimilars of Adalimumab in Psoriasis – Bioequivalence and Interchangeability
by: Zhou X, et al.
Published: (2021) -
Efficacy and safety of cyclosporin, adalimumab and secukinumab in the treatment of nail psoriasis
by: Zhanhan TANG, et al.
Published: (2023) -
Efficacy and safety of adalimumab biosimilar (HS016) in inflammatory bowel disease from the real-world study
by: Fang Wang, et al.
Published: (2023) -
The effect of biosimilar administration on clinical outcomes in patients with adalimumab‐controlled psoriasis
by: M. Panahi, et al.
Published: (2021) -
Meta-analysis of efficacy and safety of adalimumab injection for arthropathic psoriasis
by: Nan LI, et al.
Published: (2019)